Prenuvo Partners with Global Leader in Performance Health Age Management Cenegenics to Bring Comprehensive Whole-Body Scans to Patients

Prenuvo, the company pioneering proactive whole-body imaging for the early detection of cancer and other diseases, today announced its partnership with Cenegenics, a leading performance health age management platform dedicated to helping people achieve their peak cognitive, physical and metabolic health. Together, the two will bring Prenuvo’s comprehensive, radiation-free scans to thousands of current and future Cenegenics patients, empowering their physicians to make more informed health decisions to help patients achieve longer, better, and healthier lives.

Prenuvo alerts an average of one in 20 patients to a life-saving detection. The company’s whole-body MRI scans are based on 10+ years of clinical work and hold the largest dataset of whole-body MRI imaging in the world. Unlike conventional MRIs, which take hours and often involve contrast injections, Prenuvo scans for 500+ conditions, including most solid tumors which can be detected as early as stage 1, aneurysms, cysts, and more – all without radiation, in under an hour.

“We are driven by a shared vision of enhancing both healthspan and lifespan in our pursuit of transforming the healthcare paradigm from reactive to proactive,” said Prenuvo Co-Founder and CEO Andrew Lacy. “By combining Prenuvo’s advanced diagnostic-quality imaging capabilities with Cenegenics’ steadfast dedication to healthy longevity, we’re helping patients get data-driven insight into their baseline health and make lifestyle modifications before it’s too late.”

“After creating a customized radiation-free MRI technology in 2011 and meeting directly with thousands of patients and their physicians over the course of a decade, we have built a powerful process with unique capabilities. We look forward to bringing both patients and their Cenegenics physicians these unequivocal imaging insights for comprehensive health assessments and early disease detection,” said Dr. Raj Attariwala, Founding Radiologist and double board certified radiologist and nuclear medicine physician who also holds a PhD in engineering.

Cenegenics uses whole-body diagnostic data to create personalized Performance Health Age Management Programs for its patients, monitoring for 90+ biomarkers that help in ultimately slowing down the biological aging process.

“Like Prenuvo, our goal is to give patients a comprehensive, holistic view of their health so that they can proactively manage their well-being. We look forward to bringing Prenuvo’s powerful imaging tools for early detection to our patients,” said Kristy Berry, CEO of Cenegenics.

As part of Cenegenics’ comprehensive health programs, Prenuvo will provide whole-body MRI scans for Cenegenics patients at participating locations, including Los Angeles, Silicon Valley, New York, Dallas, Chicago, and Boca Raton. Referrals for Prenuvo’s scan will be facilitated through the Cenegenics patient’s dedicated Performance Health Team as a referral from a Cenegenics Physician will be required to schedule an appointment.

For more information about Prenuvo’s comprehensive body scans, please visit www.prenuvo.com. To learn more about Cenegenics and their Performance Health Age Management platform, please visit www.cenegenics.com.

About Prenuvo:

Led by Founder and CEO Andrew Lacy and Founding Radiologist and biomedical engineer Dr. Raj Attariwala, Prenuvo makes MRI scanning for early detection of cancer, “silent killers” like aneurysms, and other diseases seamless and more widely accessible. Combining cutting-edge analysis technology with radiation-free and non-invasive full-body scans, Prenuvo’s patient-centric design is optimized to assess the body holistically and in under 60 minutes, compared with the several hours it would take to achieve this level of insight from conventional MRI scans.

Prenuvo is backed by leading venture capital firms and investors in health, fitness and category-defining consumer brands such as Felicis Ventures [investors in Fitbit (IPO), Guardant Health (IPO) and Ring (acq. by Amazon)], 23AndMe CEO Anne Wojcicki, Nest founder Tony Fadell, Eric Schmidt, Cindy Crawford, Lasker award recipient Dr. Timothy A. Springer and Casamigos co-founder Rande Gerber.

Prenuvo locations include New York, Redwood City, Los Angeles, Dallas, Boca Raton, Chicago, Vancouver, and a partner location in Minneapolis; several additional locations will be opening across the country in 2023.

The company is based out of California and British Columbia, Canada.

About Cenegenics:

Founded in 1997, Cenegenics provides the world’s best Performance Health Age Management solution, fueled by sophisticated data, technology and metabolic science to motivate and inspire, helping people achieve their peak cognitive, physical and metabolic health. Having served over 44,000 patients worldwide through its 25+ year history, Cenegenics takes a comprehensive approach to preventive medicine, enabling patients to live longer, more energized lives.

With 29 locations across the globe and counting, including Beverly Hills, New York City, San Francisco, Chicago, London and Brazil, Cenegenics is on a path to partner with patients wherever they are located.

For more information on Cenegenics and its team of medical professionals, visit Cenegenics.com

Contact Information

Maggie Philbin

Partner

VSC for Prenuvo

prenuvo@vsc.co